2-es típusú cukorbetegség: vizsgálatok itt: India
32 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Ahmedabad, Mumbai, Pune, Trivandrum
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Ahmedabad, Chennai, Hyderabad, Indore, Mumbai, Pune, Trivandrum
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisNot yet taking people in IndiaA Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
- Where
- Ansārinagar, Calicut, Kolkata, Ludhiana, Meerut, Surat
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07922330 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Where
- Ahmedabad, Aligarh, Bhubaneswar, Guntur, Mumbai, Nashik, New Delhi
- Életkor
- 10 év to 17 év
- People
- 170 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Bangalore
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Allahabād, Bangalore, Chennai, Hyderabad, Jaipur, Kanpur, Kolhāpur, Mysore, Nagpur, Surat
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 3. fázisNot yet taking people in IndiaA Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Where
- Ahmedabad, Baroda, Belagavi, Chennai, Guntur, Hubli, Kanpur, Noida, Pune, Raipur, Udaipur, Vellore
- Életkor
- 18 év and over
- People
- 2115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00 - 3. fázisNot yet taking people in IndiaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Belagavi, Guntur, Guwahati, Mumbai, Nagpur, Pune, Rishikesh, Surat
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Guwahati, Indore, Jaipur, Kochi, Lucknow, Madurai, Mumbai, Nagpur, New Delhi, Thiruvananthapuram
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Bhubaneswar, Coimbatore, Hyderabad, Indore, Jaipur, Jodhpur, Kochi, Kolkata, Noida, Pune, Siliguri, Surat, Vijayawada
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisTaking peopleA Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Where
- Ahmedabad, Bhubaneswar, Cuttack, Hyderabad, Afzalgunj, Kolhāpur, Lucknow, Nagpur, Nashik, New Delhi, Pune, Trivandrum, Visakhapatnam
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07754461 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Ahmedabad, Bengaluru, Bikaner, Kanpur, Kolkata, Maharashtra, Nagpur, Nashik, New Dehi, New Delhi, Pune, Sāket, Surat, Trivandrum, Visakhapatnam
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Bangalore, Indore, Kolkata, Nagpur, Noida, Pune, Siliguri, Visakhapatnam
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleA Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Where
- Bangalore, Delhi, Guntur, Kanpur, Kolhāpur, Kolkata, New Delhi, Surat
- Életkor
- 10 év to 18 év
- People
- 80 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07282613 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Bangalore, Belagavi, Bikaner, Delhi, Guntur, Hyderabad, Jaipur, Jodhpur, Kolkata, Madurai, Mumbai, Mysore, Nagpur, New Delhi, Siliguri
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- Where
- Agra, Hyderabad, Kanpur, Kolkata, Mumbai, Mysore, Nashik, Nellore, Visakhapatna
- Életkor
- 18 év to 65 év
- People
- 130 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07613307 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Guntur, Guwahati, Hyderabad, Mandya, Mumbai, Mysore, Nagpur, Nashik, Pune, Trichy
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - No phaseTaking peopleiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Where
- Ahmedabad, Kolkata, Mumbai
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT03549754 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Aligarh, Belagavi, Belgavi, Calicut, Chennai, Coimbatore, Delhi, Guntur, Kolkata, Lucknow, Nagpur, Pune
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - 3. fázisTaking peopleAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Bangalore, Bhubaneswar, Coimbatore, Guntur, Hyderabad, Indore, Jaipur, Kochi, Kozhikode, Ludhiana, Mumbai, Nagpur, New Delhi, Pune, Raipur, Surat, Thane, Vadodara, Vellore
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - No phaseTaking peopleA Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Where
- Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Delhi, Guntur, Guwahati, Indore, Jaipur, Kochi, Kolkata, Lucknow, Mumbai, Nagpur, Pune, Thiruvananthapuram
- Életkor
- 18 év and over
- People
- 2150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07606066 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Where
- Bangalore, Belagavi, Chennai, Coimbatore, Guntur, Hyderabad, Indore, Kochi, Madurai, Mumbai, New Delhi, Pune
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00 - No phaseCsak meghívásosDevelopment of Anti-Diabetic Nutraceuticals From Legume Seed Coats
- Where
- Mysore
- Életkor
- 20 év to 60 év
- People
- 100
- Run by
- JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH
See details and how to joinNCT07688694 - No phaseTaking peopleEffect of Diode Laser, Gudmar and Vinegar in Diabetic Patients During Root Canal Treatment
- Where
- Noida
- Életkor
- 25 év to 60 év
- People
- 90
- Run by
- Sharda University
See details and how to joinNCT07549373 - No phaseTaking peopleCommunity Health Worker-Led Postpartum Diabetes Screening
- Where
- Pune
- Életkor
- 18 év and over
- People
- 330
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT06209411